1,407 Shares in Synopsys, Inc. $SNPS Acquired by Three Seasons Wealth LLC

Three Seasons Wealth LLC acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,407 shares of the semiconductor company’s stock, valued at approximately $694,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Everpar Advisors LLC increased its stake in shares of Synopsys by 8.2% in the 3rd quarter. Everpar Advisors LLC now owns 883 shares of the semiconductor company’s stock valued at $436,000 after purchasing an additional 67 shares during the last quarter. Perigon Wealth Management LLC boosted its stake in Synopsys by 14.4% in the third quarter. Perigon Wealth Management LLC now owns 2,438 shares of the semiconductor company’s stock valued at $1,203,000 after buying an additional 306 shares in the last quarter. Sowell Financial Services LLC boosted its stake in Synopsys by 4.3% in the third quarter. Sowell Financial Services LLC now owns 1,035 shares of the semiconductor company’s stock valued at $511,000 after buying an additional 43 shares in the last quarter. Bellecapital International Ltd. bought a new position in Synopsys in the third quarter valued at about $1,112,000. Finally, E. Ohman J or Asset Management AB raised its stake in Synopsys by 19.8% during the third quarter. E. Ohman J or Asset Management AB now owns 7,820 shares of the semiconductor company’s stock worth $3,858,000 after acquiring an additional 1,290 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Stock Performance

Shares of Synopsys stock opened at $477.14 on Monday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock has a market cap of $91.29 billion, a price-to-earnings ratio of 59.72, a P/E/G ratio of 3.97 and a beta of 1.16. The company’s fifty day moving average is $437.58 and its 200 day moving average is $503.62.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the company earned $3.40 EPS. Synopsys’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Piper Sandler reduced their price target on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. The Goldman Sachs Group cut their target price on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Needham & Company LLC upped their price target on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Finally, Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $562.13.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.